INDIANAPOLIS – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the appointment of Brad Moore as president and CEO of Roche Diagnostics North America, effective January 1, 2023. Moore currently serves as senior vice president, Core Lab and Point of Care, within Roche Diagnostics North America. Moore will succeed and report to Matt Sause, who […]
New collaboration will develop assays that offer a streamlined workflow for analysing even the most challenging genes. MINNEAPOLIS — Asuragen, a Bio-Techne brand (NASDAQ: TECH) and Oxford Nanopore Technologies plc (Oxford Nanopore) (LSE: ONT), today announce a collaboration to develop assays designed to deliver more accurate and reliable options for reproductive health and carrier screening. Asuragen will […]
With the debut of its novel single-cell solution and its first Grant Program, Scipio bioscience is creating an era where scRNA-seq is versatile, flexible, and accessible for every lab Caption: Scipio bioscience’s scRNA-seq solution includes the Asteria™ Benchtop Kit and the Cytonaut™ Cloud Analysis Software. Paris, France – Introduced just six months ago, the Scipio […]
Dublin, Ireland: ERS Genomics Limited (‘ERS’) is pleased to announce a new license agreement with Cosmo Bio. This is a non-exclusive license agreement granting Japan’s Cosmo Bio access to the ERS CRISPR/Cas9 patent portfolio. ERS, co-founded by Dr. Emmanuelle Charpentier, 2020 Nobel Prize winner for gene-editing, provides access to the foundational CRISPR/Cas9 intellectual property. Over […]
SINGAPORE — MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life science, will join global and Asian cancer professionals at the ESMO Asia Congress 2022 taking place 2-4 December in Singapore. In addition, MGI will introduce a free trial campaign on its latest sequencer DNBSEQ-G99* for early users […]
Rockville, MD — MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell–engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research, today announces the appointment of Patrick J. Balthrop, Sr. to the company’s Board of Directors as non-executive director with immediate effect. Mr. Balthrop is also […]
Maravai announces plans for William “Trey” Martin, III to serve as President of its Biologics Safety Testing Segment and its expectation that he will then assume the role of Maravai’s CEO in July 2023 Carl Hull to continue to serve as Executive Chairman and Interim CEO SAN DIEGO — Maravai LifeSciences, Inc. (NASDAQ: MRVI), a […]
ZURICH — BC Platforms (BCP), a global leader in healthcare data management and analytics, today announced that, together with Finland’s Euformatics and Hungary’s Oncompass Medicine, the BCP-led partnership has now successfully been awarded contract for the second phase of developing standardized oncology workflows for a buyer consortium of seven leading central European hospitals*, represented by the Medical University Graz. This […]
Combining enzymology and lyophilization expertise for best-in-class solutions for in vitro diagnostics IPSWICH, Mass. — New England Biolabs (NEB®), a leading supplier of life science reagents, introduces New England Biolabs Lyophilization Sciences (NEB Lyo Sciences™) – a wholly owned subsidiary of NEB with expertise in the design, development and manufacturing of innovative solutions for ambient stored […]
Caption: Dolomite Bio’s RNAdia 2.0 kit and the Nadia Instrument. Dolomite Bio launches the RNAdia 2.0 reagent kit for single cell research, as part of their complete workflow, encompassing everything from sample preparation to bioinformatic analysis.Most researchers will be familiar with the frustrations of sourcing reagents, which wastes precious time when performing a standardized single […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
